Abstract
Cancer cell-derived small extracellular vesicles (sEVs) are new promising biomarkers for improved cancer diagnosis. A multi-line lateral flow immunoassay (LFIA) has been proposed for sensitive detection and subtyping of breast cancer-derived sEVs. The expression of cancer surface biomarkers (EpCAM) was confirmed through colorimetric analysis of cell line-derived sEVs (p = 0.076) and patient samples, highlighting the potential for their use as a clinical aid.
Original language | English |
---|---|
Pages (from-to) | 8915–8918 |
Number of pages | 4 |
Journal | Chemical Communications |
Volume | 61 |
Issue number | 49 |
Early online date | 21 May 2025 |
DOIs | |
Publication status | Published - 21 Jun 2025 |